Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG624855 Inhibitors

Cks1brt, a retrotransposed duplicate of CDC28 protein kinase 1b, exhibits a predicted multifaceted role in cellular processes, primarily involving its participation in the regulation of the mitotic cell cycle. Its functional repertoire encompasses activities such as cyclin-dependent protein serine/threonine kinase activation, histone binding, and ubiquitin binding, indicating its involvement in key molecular events governing cell division. The orthologous relationship with human CKS1B suggests evolutionary conservation of these functions across species, underscoring the biological significance of Cks1brt. Central to the modulation of Cks1brt is the intricate network of cyclin-dependent kinases (CDKs), vital components orchestrating cell cycle progression. Direct inhibitors targeting CDKs, such as Roscovitine, Purvalanol A, and Dinaciclib, disrupt the normal course of the cell cycle, leading to arrest and subsequent suppression of Cks1brt activity. These inhibitors interfere with the cyclin-dependent protein kinase holoenzyme complex, intricately linked to the regulation of the mitotic cell cycle. Indirect inhibitors, like Cisplatin, exert their influence by inducing DNA damage, activating cell cycle checkpoints, and affecting Cks1brt activity. This underscores the interconnected nature of cell cycle regulation and DNA repair mechanisms, emphasizing the broader implications of Cks1brt in maintaining cellular homeostasis.

In summary, Cks1brt emerges as a pivotal player in the orchestration of mitotic cell cycle dynamics, wielding its influence through multifunctional activities. The general mechanisms of inhibition primarily revolve around the modulation of CDKs, the principal actors in the cell cycle narrative. Direct inhibitors disrupt the finely tuned interplay of CDKs, inducing cell cycle arrest and subsequently affecting Cks1brt function. Indirect inhibitors, through DNA damage induction, further underscore the intricate link between cell cycle regulation and DNA repair processes, implicating Cks1brt in these fundamental cellular activities. The intricate web of molecular interactions involving Cks1brt and its inhibition opens avenues for deeper exploration into the underlying mechanisms governing cell cycle progression.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Polo-like Kinase Inhibitor III

660868-91-7sc-203202
500 µg
$109.00
1
(0)

A direct inhibitor of Cks1brt through inhibition of CDKs, leading to cell cycle arrest and suppression of Cks1brt activity. It interferes with the cyclin-dependent protein kinase holoenzyme complex, influencing the regulation of mitotic cell cycle.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin is an indirect inhibitor of Cks1brt by inducing DNA damage and activating the G1/S checkpoint, resulting in cell cycle arrest and affecting Cks1brt activity. It indirectly influences the regulation of mitotic cell cycle by disrupting DNA synthesis and repair processes.